ARTICLE | Finance
Canada’s Sagard gaining healthcare foothold via royalty fund
Starting with a Rubraca deal, alternative asset manager Sagard believes royalties are the way into healthcare investing
February 18, 2020 4:16 PM UTC
Updated on Feb 19, 2020 at 6:25 PM UTC
Canadian alternative asset management firm Sagard Holdings is dipping its toe into life sciences investments via a new royalty fund, which has raised $475 million in a first close.
The firm isn’t disclosing the final target for Sagard Healthcare Royalty Partners, but the firm’s David MacNaughtan told BioCentury he expects the fund to close by year end. The parent company has put in $75 million; Sagard said it is joined by other undisclosed “anchor investors.”...